State Street Corp Inozyme Pharma, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, State Street Corp holds 880,639 shares of INZY stock, worth $4.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

880,639

Previous 746,533 17.96%

Holding current value

$4.24 Million

Previous $3.18 Million 112.11%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.14 - $7.66 $555,198 - $1.03 Million	134,106 Added 17.96%	880,639 $6.75 Million
Q4 2023 Feb 14, 2024	BUY	$2.71 - $4.5 $320,284 - $531,837	118,186 Added 18.81%	746,533 $3.18 Million
Q3 2023 Nov 14, 2023	BUY	$4.09 - $7.0 $276,095 - $472,535	67,505 Added 12.04%	628,347 $2.64 Million
Q2 2023 Aug 14, 2023	BUY	$4.93 - $6.74 $2.28 Million - $3.12 Million	462,787 Added 471.97%	560,842 $3.12 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $5.73 $28,210 - $124,341	21,700 Added 28.42%	98,055 $561,000

Q3 2022 Nov 15, 2022	BUY	$2.62 - $5.45 $71,526 - $148,785	27,300 Added 55.65%	76,355 $205,000
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.96 $447,840 - $834,102	-139,950 Reduced 74.05%	49,055 $234,000
Q1 2022 May 16, 2022	BUY	$3.87 - $7.55 $7,364 - $14,367	1,903 Added 1.02%	189,005 $773,000
Q4 2021 Feb 14, 2022	SELL	$5.58 - $11.5 $6,500 - $13,397	-1,165 Reduced 0.62%	187,102 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$11.12 - $19.4 $204,363 - $356,533	18,378 Added 10.82%	188,267 $2.18 Million
Q2 2021 Aug 16, 2021	BUY	$15.19 - $21.2 $572,207 - $798,604	37,670 Added 28.49%	169,889 $2.9 Million
Q1 2021 May 17, 2021	BUY	$17.77 - $27.9 $260,152 - $408,456	14,640 Added 12.45%	132,219 $2.62 Million
Q4 2020 Feb 16, 2021	BUY	$19.95 - $27.55 $937,530 - $1.29 Million	46,994 Added 66.58%	117,579 $2.43 Million
Q3 2020 Nov 10, 2020	BUY	$17.54 - $30.2 $1.24 Million - $2.13 Million	70,585 New	70,585 $1.86 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

49M

Call Options Held

1.6K

Put Options Held

22K

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $194M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Inozyme Pharma, Inc. Transaction History